enVVeno Medical Corporation (FRA:5HJ)
0.2940
0.00 (0.00%)
At close: Nov 28, 2025
enVVeno Medical Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 1.54 | 1.75 | 3.62 | 4.56 | 54.73 | 9.33 | Upgrade |
Short-Term Investments | 29.41 | 41.4 | 42.79 | 34.49 | - | - | Upgrade |
Cash & Short-Term Investments | 30.95 | 43.15 | 46.41 | 39.04 | 54.73 | 9.33 | Upgrade |
Cash Growth | -36.02% | -7.02% | 18.87% | -28.66% | 486.29% | 614.07% | Upgrade |
Prepaid Expenses | 0.55 | 0.58 | 0.51 | 0.39 | 0.31 | 0.23 | Upgrade |
Total Current Assets | 31.5 | 43.73 | 46.92 | 39.44 | 55.04 | 9.57 | Upgrade |
Property, Plant & Equipment | 0.82 | 1.19 | 1.68 | 2.19 | 2.61 | 0.94 | Upgrade |
Other Long-Term Assets | 0.03 | 0.03 | 0.03 | 0.03 | 0.05 | 0.03 | Upgrade |
Total Assets | 32.35 | 44.95 | 48.64 | 41.66 | 57.7 | 10.54 | Upgrade |
Accounts Payable | 0.63 | 1.01 | 0.43 | 0.65 | 0.56 | 1.39 | Upgrade |
Accrued Expenses | 1.49 | 0.73 | 0.61 | 0.57 | 0.73 | 0.98 | Upgrade |
Short-Term Debt | - | - | - | - | - | 0.31 | Upgrade |
Current Portion of Leases | 0.29 | 0.36 | 0.34 | 0.31 | 0.29 | 0.31 | Upgrade |
Other Current Liabilities | - | - | - | - | - | 0.19 | Upgrade |
Total Current Liabilities | 2.4 | 2.1 | 1.37 | 1.53 | 1.58 | 3.19 | Upgrade |
Long-Term Leases | 0.51 | 0.7 | 1.06 | 1.4 | 1.72 | 0.25 | Upgrade |
Total Liabilities | 2.91 | 2.8 | 2.44 | 2.93 | 3.3 | 3.44 | Upgrade |
Common Stock | - | - | - | - | - | 0 | Upgrade |
Additional Paid-In Capital | 197.04 | 194.01 | 176.24 | 145.25 | 136.26 | 72.42 | Upgrade |
Retained Earnings | -167.59 | -151.86 | -130.04 | -106.52 | -81.85 | -65.32 | Upgrade |
Total Common Equity | 29.45 | 42.16 | 46.2 | 38.73 | 54.4 | 7.1 | Upgrade |
Shareholders' Equity | 29.45 | 42.16 | 46.2 | 38.73 | 54.4 | 7.1 | Upgrade |
Total Liabilities & Equity | 32.35 | 44.95 | 48.64 | 41.66 | 57.7 | 10.54 | Upgrade |
Total Debt | 0.79 | 1.06 | 1.4 | 1.72 | 2.01 | 0.88 | Upgrade |
Net Cash (Debt) | 30.16 | 42.09 | 45.01 | 37.33 | 52.72 | 8.45 | Upgrade |
Net Cash Growth | -36.14% | -6.49% | 20.58% | -29.20% | 523.64% | 1776.16% | Upgrade |
Net Cash Per Share | 1.49 | 2.46 | 3.66 | 3.94 | 6.07 | 6.55 | Upgrade |
Filing Date Shares Outstanding | 20.22 | 17.54 | 13.32 | 9.47 | 9.47 | 8.5 | Upgrade |
Total Common Shares Outstanding | 20.22 | 17.54 | 13.32 | 9.47 | 9.47 | 2.54 | Upgrade |
Working Capital | 29.1 | 41.64 | 45.55 | 37.91 | 53.46 | 6.38 | Upgrade |
Book Value Per Share | 1.46 | 2.40 | 3.47 | 4.09 | 5.74 | 2.79 | Upgrade |
Tangible Book Value | 29.45 | 42.16 | 46.2 | 38.73 | 54.4 | 7.1 | Upgrade |
Tangible Book Value Per Share | 1.46 | 2.40 | 3.47 | 4.09 | 5.74 | 2.79 | Upgrade |
Machinery | - | 1.44 | 1.4 | 1.37 | 0.81 | 0.48 | Upgrade |
Leasehold Improvements | - | - | - | - | 0.19 | 0.16 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.